Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes

Clinical and Experimental Immunology

Volumn 113, Issue 2, 1998, Pages 269-275

  Lambert, N ^a   Lescoulie P L ^a   Yassine Diab, B ^a   Enault, G ^a   Mazieres B ^b   De Preval C ^a   Cantagrel, A ^a,b  

^a CHU PURPAN   (France)

^b CHU RANGUEIL   (France)

Author keywords

NK1 receptor; Rheumatoid arthritis; Tachykinins; Type B synoviocyte

Indexed keywords

CD40 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SYNOVIOCYTE;

ANTIGENS, CD40; ANTIGENS, CD58; ANTIGENS, CD80; ARTHRITIS, RHEUMATOID; DRUG INTERACTIONS; FIBROBLASTS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-1; RECEPTORS, TACHYKININ; RNA, MESSENGER; SUBSTANCE P; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031903047     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00621.x     Document Type: Article

References (37)

1. Palmer DG. The anatomy of the rheumatoid lesion. Br Med Bull 1945; 51:286-95.
2. Burmester GR, Dimitriu-Bona A, Waters SJ, Winchister RJ. Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts. Scand J Immunol 1983; 17:69-82.
3. Amento EP, Bhan AK, McCullagh KG, Krane SM. Influences of IFNγ on synovial-like cells. Ia induction and inhibition of collagen synthesis. J Clin Invest 1985; 76:837-48.
4. Boots AMH, Wimmers-Bertens AJMH, Rijnders AWM. Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology 1994; 82:268-74.
5. Matucci-Cerini M, Marabini S, Partsch G, Cagnoni M. High levels of substance P in rheumatoid arthritis synovial fluid. Lack of substance P production by synoviocytes in vitro. Clin Exp Rheumatol 1991; 9:441-2.
6. Maggi CA. Review: the mammalian tachykinin receptors. Gen Pharmacol 1995; 26:911-44.
7. Eglezos A, Andrews PV, Boyd RL, Helme RD. Modulation of the immune response by tachykinins. Immunol Cell Biol 1991; 69:285-94.
8. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241:1218-21.
9. Lotz M, Carson DA, Vaughan JH. Substance P activation of rheumatoid synoviocytes neural pathway in pathogenesis of arthritis. Science 1987; 235:893-5.
10. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
11. Eistetter HR, Mills A, Brewster R, Alouani S, Rambosson C, Kawashima E. Functional characterization of neurokinine-1 receptors on human U373 MG astrocytoma cells. Glia 1992; 6:89-95.
12. Takeda Y, Chou KB, Takeda J, Sachais BS, Krause JE. Molecular cloning, structural characterization and functional expression of the human substance P receptor. Biochem Biophys Res Commun 1991; 179:1232-40.
13. Larsson J, Ekblom A, Henriksson K, Lundeberg T, Theodorsson E. Concentration of substance P, neurokinin A, calcitonin gene related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol 1991; 20:326-5.
14. Lam FY, Ferrel WR. Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser doppler perfusion imaging. Neurosci 1992; 52:443-9.
15. Okayama Y, el-Lati SG, Leiferman KM, Church MK. Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells. J Allergy Clin Immunol 1994; 93:900-9.
16. Wozniack A, Betts WH, McLennan G, Scicchitano R. Activation of human neutrophils by tachykinins: effect on formyl-methionyl-leucylphenylalanine- and platelet-activating factor-stimulated superoxide anion production and antibody-dependent cell-mediated cytotoxicity. Immunology 1993; 78:629-34.
17. Payan DG, Brewster DR, Goetzl EJ. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983; 131:1613-5.
18. Scicchitano R, Bienenstock J, Stanisz AM. In vivo immunomodulation by the neuropeptide substance P. Immunology 1988; 63:733-5.
19. Agro A, Stanisz AM. Are lymphocytes a target for substance P modulation in arthritis? Sem Arthritis Rheum 1992; 21:252-8.
20. En Chin J, Winterrowd GE, Krzesicki RF, Sanders ME. Role of cytokines in inflammatory synovitis. Arthritis Rheum 1990; 33:1776-86.
21. Rissoan MC, Van Kooten C, Chomarat P, Galibert L, Durand I, Thivolet-Bejui F, Miossec P, Banchereau J. The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium. Clin Exp Immunol 1996; 106:481-90.
22. Lindsley HB, Smith DS, Davis LS, Koch AE, Lipsky P. Regulation of the expression of adhesion molecules by human synoviocytes. Sem Arthritis Rheum 1992; 21:330-4.
23. Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Garcia JM, Zwaifler NJ, Firestein GS. A4/β1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 1992; 149:1424-31.
24. Balsa A, Dixey J, Sansom DM, Maddisson PJ, Hall ND. Differential expression of the costimulatory molecule B7.1 (CD80) and B7.2 (CD86) in rheumatoid synovial tissue. Br J Rheumatol 1996; 35:33-37.
25. Liu MF, Kohsaka H, Sarukai H, Azuma M, Okumura K, Saito I. Miyasaka N. The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium. Arthritis Rheum 1996; 391:110-4.
26. Looney RJ, Hooper M, Pudiak D. Costimulatory activity of human synovial fibroblasts. J Rheumatol 1995; 22:1820-4.
27. Tsai C, Diaz LA, Singer NG et al. Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. Arthritis Rheum 1996; 39:125-36.
28. Geppert TD, Lipsky PE. Dissection of defective antigen presentation by interferon γ-treated fibroblasts. J Immunol 1987; 138:385-92.
29. Van Dinther-Janssen ACHM, Kraal G, van Soesbergen RM, Scheper RJ, Meijer CJLM. Immunohistological and functional analysis of adhesion molecule expression in the rheumatoid synovial lining cell destruction. J Rheumatol 1994; 21:1998-2004.
30. Kriegsmann J, Keyszer GM, Geiler T, Brauer R, Gay RE, Gay S. Expression of VCAM-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunochemistry. Lab Invest 1995; 72:209-14.
31. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum 1996; 39:1781-90,
32. Jorgensen C, Sany J. Modulation of the immune response by the neuroendocrine axis in rheumatoid arthritis. Clin Exp Rheumatol 1994; 12:435-41.
33. Saban MR, Saban R, Bjorling D, Haak-Frendscho M. Involvement of leucotrienes, TNF-α, and the LFA-1/ICAM-1 interaction in substance P-induced granulocyte infiltration. J Leuk Biol 1997; 61: 445-51.
34. Chen CC, Rosenhloom CL, Anderson DC, Manning AM. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of IkB-a phosphorylation. J Immunol 1995; 155:3538-45.
35. Ledebur HC, Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem 1995; 270:933-43.
36. Krause JE, DiMaggio DA, McCarson KE. Alterations in neurokinin 1 receptor gene expression in models of pain and inflammation. Can J Physiol Pharmacol 1995; 73:854-9.
37. Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ. Substance P recognition by a subset of human T lymphocytes. J Clin Invest 1984; 74:1532-9.